• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Lupin launches generic Vigamox Ophthalmic solution in the US

expressbpdJuly 06, 2017

Tag: lupin , Vigamox Ophthalmic solution , US

Lupin has announced the launch of its Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5 per cent (base) having received an approval from the United States Food and Drug Administration (FDA) earlier. The launched product is from Lupin’s Pithampur manufacturing facility.

Lupin’s Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5 per cent (base), is an AT1 rated generic equivalent of Novartis Pharms Corp.’s Vigamox Ophthalmic solution. It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms.

Previous:Alzheimer's and Parkinson's spurred by same enzyme

Next:Granules India gets board nod to raise foreign investment limit

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Lupin launches generic Vigamox Ophthalmic solution in the US | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

B-XL series continuous vacuum pulverizing unit

B-XL series continuous vacuum pulverizing unit
Celastrus angulatus

Celastrus angulatus

leak test apparatus price

leak test apparatus price
Haematococcus pluvialis powder 3%

Haematococcus pluvialis powder 3%
penicillin G Procaine +dihydrostreptomycin sulfate suspension

penicillin G Procaine +dihydrostreptomycin sulfate suspension
VHP pass box used in pharmaceutical industry

VHP pass box used in pharmaceutical industry
JCFJ Series Inner-Grading Mechanical Crusher

JCFJ Series Inner-Grading Mechanical Crusher
Root Polyphenol Dried Seeds Manufacturers Oil Angustifolia Gummies Pallida Echinacea Purpurea Extrac

Root Polyphenol Dried Seeds Manufacturers Oil Angustifolia Gummies Pallida Echinacea Purpurea Extrac
Astragalus Extract Powder

Astragalus Extract Powder
15 Ton 15hp Industrial Water Cooled Chillers Hermetic Scroll

15 Ton 15hp Industrial Water Cooled Chillers Hermetic Scroll

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service